BRIEF-Dogwood Therapeutics Announces Low Dose IMC-2 Treatment

Reuters
18 Nov 2024

Nov 18 (Reuters) - Dogwood Therapeutics Inc :

* DOGWOOD THERAPEUTICS, INC. ANNOUNCES LOW DOSE IMC-2 TREATMENT REDUCES LONG-COVID RELATED FATIGUE AND SLEEP DISTURBANCE IN AN INVESTIGATOR-INITIATED STUDY

* DOGWOOD THERAPEUTICS INC - IMC-2 SHOWS ROBUST REDUCTION IN FATIGUE

Source text: Further company coverage:

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10